Protected: Liver Cancer vs. Liver Metastases: What’s the Difference?

by Delcath Systems | Sep 25, 2026 | Patient Education

Password Protected

To view this protected post, enter the password below:

Immersive Innovation at CIRSE 2026: Experiencing the Future of Percutaneous Hepatic Perfusion

by Delcath Systems | Sep 25, 2026 | Events

Bringing Procedure Visualization to Life Through Virtual Reality At the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2026 conference in Copenhagen, Delcath Systems introduced attendees to a new way of understanding the percutaneous hepatic...

Understanding Metastatic Uveal Melanoma: Why the Liver Matters

by Delcath Systems | Sep 11, 2026 | Patient Education

For someone diagnosed with uveal melanoma, you may hear your healthcare team discuss the possibility of metastasis and the importance of monitoring the liver. Understanding what these terms mean can make follow-up conversations easier to navigate. What does...

Protected: Liver Cancer vs. Liver Metastases: What’s the Difference?

Password Protected

Immersive Innovation at CIRSE 2026: Experiencing the Future of Percutaneous Hepatic Perfusion

Understanding Metastatic Uveal Melanoma: Why the Liver Matters

Get more information from our dedicated team revolutionizing the treatment of patients with cancers of the liver.

Connect with Us